Results 231 to 240 of about 73,620 (322)
In our central morphological review system, megakaryocyte counts are prioritized alongside BM cellularity to differentiate between AA and MDS. A retrospective analysis of patients with SAA and those with LR‐hMDS, registered in that system, revealed a significant difference in outcomes.
Tomoya Maeda+25 more
wiley +1 more source
Chromosomes of four species of dobsonflies, in the genus <i>Protohermes</i> (Megaloptera, Corydalidae, Corydalinae) from East Asia. [PDF]
Takeuchi Y+3 more
europepmc +1 more source
Multiple myeloma (MM) with chromosome 1q21 gain/amplification (1q+) has been reported to respond poorly to daratumumab, a human monoclonal antibody targeting CD38. Our findings revealed significantly lower CD38 expression in patients with 1q+ MM than in those with 1q wild type (WT) MM.
Wataru Kuroki+9 more
wiley +1 more source
Editorial: MDS: new scientific and clinical developments. [PDF]
Blum S, Symeonidis A, Germing U.
europepmc +1 more source
In this study, we explored the effects of silenced STAB1 expression in AML cells on the polarization of M2‐like macrophages, as well as the involvement of nuclear factor‐kappa B (NF‐κB) signaling pathways in the pro‐oncogenic roles of STAB1. By investigating the expression pattern of STAB1 along with its regulatory mechanisms in AML patients, we aimed ...
Jiaxiu Yin+4 more
wiley +1 more source
Case Report - Severe hypospadias in 46, XY karyotype patients: is third level genetic testing always mandatory? [PDF]
Romano G+5 more
europepmc +1 more source
Pimitespib, an HSP90 inhibitor, enhances the antitumor activity of PARP inhibitors by impairing the homologous recombination (HR) repair pathway in PARP inhibitor‐insensitive breast cancer cells. This is achieved by promoting the downregulation of proteins involved in HR, such as BRCA1, BRCA2, and RAD51.
Hiromi Muraoka+4 more
wiley +1 more source
Extramedullary Relapse of Acute Promyelocytic Leukaemia (APL) at an Unusual Site (External Auditory Canal). [PDF]
Iyer P+4 more
europepmc +1 more source